Citaat | Gerechtshof Den Haag 27 februari 2018

Onder 2.6. Gerechtshof Den Haag 27 februari 2018

Een alinea uit Gerechtshof Den Haag 27 februari 2018, ECLI:NL:GHDHA:2018:4021.

[0023] An injection device for a single application according to the present invention preferably contains a dose of the active substance methotrexate of 5 mg to 40 mg. It is especially preferred that an injection device for a single application according to the present invention contains a dose of 5.0, 7.5, 10.0, 12.5, 15.0, 17.5, 20.0, 22.5, 25.0, 27.5, 30.0, 32.5, 35.0, 37.5 or 40.0 mg. The volume of the liquid necessary to provide the desired dose, which has to be contained in the injection device for a single application, depends on the concentration of the active substance solution and is obvious to the person skilled in the art. Thus, in order to provide a dose of active substance of 30.0 mg at a methotrexate concentration according to the present invention in the pharmaceutically acceptable solvent of 50 mg/ml, an injection device for a single application would have to contain a liquid volume of 0.6 ml.

Zelf controleren

Voor dit citaat hoeft niemand Bron op zijn woord te geloven. Het document dat rechtspraak.nl publiceerde, staat op https://bron.page/api/v1/blobs/718f88bde98e83a98fc7d62d05e5882e80e36c73be278946d4fb7af540e35d74. Wie het ophaalt en de SHA-256 ervan berekent, krijgt 718f88bde98e83a98fc7d62d05e5882e80e36c73be278946d4fb7af540e35d74, en de alinea staat in dat document op bytes 33335 tot 34272.